CARDIOMYOPATHY, DILATED, 2B
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy.
|
21965549 |
2011 |
CARDIOMYOPATHY, DILATED, 2B
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
CARDIOMYOPATHY, DILATED, 2B
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
CARDIOMYOPATHY, DILATED, 2B
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Familial dilated cardiomyopathy
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy.
|
21965549 |
2011 |
Cardiomyopathies
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Cardiomyopathy, Dilated
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Lipodystrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myopathy
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Creatine phosphokinase serum increased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neutrophil abnormality
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Electromyogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Lipoatrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Keratoderma, Palmoplantar
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
To date, the relationship between GATAD1 amplification and glioma oncogenesis and malignancy is still unknown.
|
31286678 |
2019 |
Glioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
To date, the relationship between GATAD1 amplification and glioma oncogenesis and malignancy is still unknown.
|
31286678 |
2019 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
The MTT and orthotopic tumor transplantation assays were used to identify the function of GATAD1 in glioma proliferation. cDNA microarray, ChIP qPCR, EMSA and 3C were used to screen the downstream mechanism of GATAD1 regulating glioma proliferation.
|
31286678 |
2019 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
To date, the relationship between GATAD1 amplification and glioma oncogenesis and malignancy is still unknown.
|
31286678 |
2019 |
Adult Liver Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.
|
29266303 |
2018 |
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.
|
29266303 |
2018 |
Malignant neoplasm of liver
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.
|
29266303 |
2018 |
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
GATAD1 may serve as an independent poor prognostic factor for HCC patients.(Hepatology 2018;67:2302-2319).
|
29266303 |
2018 |
Choriocarcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The positive correlation between 3 [prime] methylation and GATAD1 expression was confirmed by treatment of choriocarcinoma JAR cells with DNMT inhibitor.
|
24462704 |
2014 |